Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-795,808
Closed -$17.1M 371
2015
Q3
$17.1M Sell
795,808
-235,832
-23% -$5.26M 0.23% 127
2015
Q2
$20.6M Sell
1,031,640
-11,888
-1% -$209K 0.22% 136
2015
Q1
$16.3M Sell
1,043,528
-20,260
-2% -$306K 0.17% 135
2014
Q4
$14.6M Sell
1,063,788
-864,904
-45% -$10.6M 0.15% 144
2014
Q3
$19.3M Sell
1,928,692
-244,404
-11% -$2.5M 0.2% 130
2014
Q2
$21.5M Sell
2,173,096
-897,296
-29% -$7.95M 0.21% 136
2014
Q1
$31.7M Sell
3,070,392
-561,596
-15% -$5.8M 0.31% 107
2013
Q4
$32.2M Sell
3,631,988
-48,984
-1% -$388K 0.32% 118
2013
Q3
$26M Sell
3,680,972
-88,152
-2% -$559K 0.27% 123
2013
Q2
$21.2M Buy
+3,769,124
New +$18.1M 0.23% 142

Other funds holding DXCM

Wasatch Advisors's DXCM Position: Q4 2015 in Review

Wasatch Advisors sold out of DexCom (DXCM) in Q4 2015, closing a stake of 795,808 shares — an estimated $17.1M sold.

Wasatch Advisors first reported a position in DXCM in Q2 2013 and held it in 10 quarters. The position peaked at $32.2M in Q4 2013. 287 funds tracked by Wall St. Rank hold DXCM as of Q4 2015.

  • Wasatch Advisors reported no remaining DexCom position as of Q4 2015 after selling out during the quarter.
  • Wasatch Advisors sold 795,808 DexCom shares in Q4 2015, an estimated $17.1M.
  • Wasatch Advisors first reported a position in DexCom in Q2 2013 and held it in 10 quarters.
  • Wasatch Advisors's DexCom position peaked at $32.2M in Q4 2013.
  • 287 funds tracked by Wall St. Rank held DexCom as of Q4 2015.

Based on Wasatch Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.